News

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...
Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...
Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
Eli Lilly’s shares shot up 11% pre-market on Thursday after orforglipron became the first small-molecule GLP-1 drug to ace a ...
What does it take to become the CEO of India's biggest biotech company and the richest woman in India? Kiran Mazumdar-Shaw, founder of biotech pharaceutical company Biotech answers your questions, ...
In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...
(InvestigateTV) — Injectable drugs for weight loss are touted as game-changers, but the results can come at a high cost. Plus, life-altering news resulted in a cycle of testing, scans and ...
Semaglutide is an injectable medication ... treats type 2 diabetes and obesity by regulating blood sugar levels. Certain foods, like sweets, candy, soda, and fried foods, can quickly raise blood sugar ...
Biologics basics: One of the best known biologics, insulin, has been around for more than 100 years. Some of the other well-known biologics are powerful, relatively new anti-inflammatory drugs ...
But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to ... half got a placebo injection. The participants ...